Contrasting QHSLab (USAQ) and Its Rivals

Risk and Volatility QHSLab has a beta of -0.66, indicating that its share price is 166% less volatile than the S&P 500. Comparatively, QHSLab’s competitors have a beta of 0.47, indicating that their average share price is 53% less volatile than the S&P 500. Profitability This table compares QHSLab and its competitors’ net margins, return [...]

featured-image

Risk and Volatility QHSLab has a beta of -0.66, indicating that its share price is 166% less volatile than the S&P 500. Comparatively, QHSLab’s competitors have a beta of 0.

47, indicating that their average share price is 53% less volatile than the S&P 500. Profitability This table compares QHSLab and its competitors’ net margins, return on equity and return on assets. Valuation and Earnings This table compares QHSLab and its competitors top-line revenue, earnings per share (EPS) and valuation.



Insider and Institutional Ownership 47.7% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 74.

2% of QHSLab shares are held by insiders. Comparatively, 15.5% of shares of all “Surgical & medical instruments” companies are held by insiders.

Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Summary QHSLab competitors beat QHSLab on 5 of the 9 factors compared. QHSLab Company Profile ( Get Free Report ) QHSLab, Inc.

, a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians.

Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc.

in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC.

QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida. Receive News & Ratings for QHSLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QHSLab and related companies with MarketBeat.

com's FREE daily email newsletter ..